Clinical trials for Lymphoma
24 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 2NCT07372352Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCLThe First Affiliated Hospital of Soochow University
- RECRUITINGPhase 1NCT07198087A Study to Investigate the Pharmacokinetics of Tirabrutinib in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Healthy ParticipantsOno Pharmaceutical Co. Ltd · PI: Project Leader
- RECRUITINGN/ANCT07191431A Clinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX Intolerance) or Temozolomide (TMZ) Combined With Orelabrutinib and Selinexor in Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma（SELINA）Ruijin Hospital
- RECRUITINGPHASE1, PHASE2NCT07018752A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell LymphomasThe Lymphoma Academic Research Organisation · PI: François LEMONNIER, Pr
- RECRUITINGN/ANCT07058064WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)Mayo Clinic · PI: Joerg Herrmann, MD
- RECRUITINGPhase 1NCT06699771Phase 1 to Investigate the Safety, Tolerability, and Efficacy of GCC2005 in Patients With R/R NK and T-cell MalignanciesGC Cell Corporation
- RECRUITINGPhase 2NCT06530550PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell LymphomasInstitute of Hematology & Blood Diseases Hospital, China · PI: Shuhua Yi, Doctor
- RECRUITINGN/ANCT06296368DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology ClinicsUNC Lineberger Comprehensive Cancer Center · PI: Daniel R Richardson, MD, MA, MSc
- RECRUITINGN/ANCT06270667Effects of Exercise Training in Survivors of LymphomaNorwegian School of Sport Sciences · PI: Tormod S. Nilsen, PhD
- ACTIVE NOT RECRUITINGN/ANCT06026046Feasibility of an Adapted Sports Program Based on Fencing to Reduce Physical Deconditioning in Adult Hematology PatientsUniversity Hospital, Angers · PI: Aline MD Schmidt, PHD
- RECRUITINGN/ANCT05940272Study of a Communication Training Intervention for Large B-Cell Lymphoma ProvidersMemorial Sloan Kettering Cancer Center · PI: Kelly McConnell, PhD
- RECRUITINGNCT06241729Prospective Observational Study of Diffuse Large-cell B LymphomaGrand Hôpital de Charleroi · PI: Delphine Pranger, MD
- RECRUITINGNCT06073938Compassionate Use Study of NHWD-870 in Patients With Advanced Solid Tumors or Lymphomas Carrying NUT RearrangementHunan Province Tumor Hospital
- RECRUITINGNCT05506410A Clinical Study of Hanlikang and BTK Inhibitors in the Treatment of Newly Diagnosed Mantle Cell LymphomaZhengzhou University · PI: Zhang Mingzhi Zhang
- ACTIVE NOT RECRUITINGPhase 1NCT05081479A Study of N-Acetylcysteine (N-AC) in People Receiving CAR T-cell Therapy for LymphomaMemorial Sloan Kettering Cancer Center · PI: Gunjan Shah, MD
- RECRUITINGPhase 1NCT04807881Phase Ib Clinical Study of KeynatinibMedolution Ltd. · PI: Dawei Zhang, phD
- ACTIVE NOT RECRUITINGN/ANCT04478318Comparison of Imaging Characteristics of uEXPLORER and Conventional PET/CT in Patients With Lung Cancer, Lymphoma, and MelanomaUniversity of California, Davis · PI: Lorenzo Nardo, MD
- ACTIVE NOT RECRUITINGPhase 2NCT06400238Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Expression (MATCH - Subprotocol Z1H)National Cancer Institute (NCI) · PI: Filip Janku
- ACTIVE NOT RECRUITINGPhase 2NCT05490771Testing Copanlisib as a Potential Targeted Treatment in Cancers With PIK3CA Mutations (MATCH-Subprotocol Z1F)National Cancer Institute (NCI) · PI: Senthilkumar Damodaran
- RECRUITINGNCT03494296A Prospective Study of Low-dose Decitabine Combined With COP Regimen in the Treatment of Relapsed and Refractory DLBCLFirst Affiliated Hospital of Harbin Medical University · PI: Shuye Wang, PhD
- ACTIVE NOT RECRUITINGPhase 2NCT04439149Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Genetic Changes (MATCH-Subprotocol N)National Cancer Institute (NCI) · PI: Filip Janku
- ACTIVE NOT RECRUITINGPhase 2NCT04439279Testing Trametinib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol R)National Cancer Institute (NCI) · PI: Douglas B Johnson
- RECRUITINGPhase 2NCT02106988Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell LymphomaM.D. Anderson Cancer Center · PI: Bouthaina Dabaja, MD
- ENROLLING BY INVITATIONNCT01382082Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving ChemotherapyUniversity of Rochester NCORP Research Base · PI: Michelle C. Janelsins, PhD